Reuters logo
2 months ago
BRIEF-Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland
June 12, 2017 / 6:08 AM / 2 months ago

BRIEF-Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland

June 12 (Reuters) - HERANTIS PHARMA OYJ:

* HERANTIS PHARMA'S CLINICAL STUDY WITH CDNF IN PARKINSON'S DISEASE AUTHORIZED IN FINLAND, COMPANY EXPANDS ON DEVELOPMENT PLAN Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below